These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 20331929)

  • 21. Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review.
    Hjorthøj C; Fohlmann A; Nordentoft M
    Addict Behav; 2009; 34(6-7):520-5. PubMed ID: 19268481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders.
    Baker A; Turner A; Kay-Lambkin FJ; Lewin TJ
    Addict Behav; 2009 Oct; 34(10):852-8. PubMed ID: 19299087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reasons for substance use among people with mental disorders.
    Thornton LK; Baker AL; Lewin TJ; Kay-Lambkin FJ; Kavanagh D; Richmond R; Kelly B; Johnson MP
    Addict Behav; 2012 Apr; 37(4):427-34. PubMed ID: 22197045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of Cannabis Use Disorder: Current Science and Future Outlook.
    Sherman BJ; McRae-Clark AL
    Pharmacotherapy; 2016 May; 36(5):511-35. PubMed ID: 27027272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Tourjman SV; Buck G; Jutras-Aswad D; Khullar A; McInerney S; Saraf G; Pinto JV; Potvin S; Poulin MJ; Frey BN; Kennedy SH; Lam RW; MacQueen G; Milev R; Parikh SV; Ravindran A; McIntyre RS; Schaffer A; Taylor VH; van Ameringen M; Yatham LN; Beaulieu S
    Can J Psychiatry; 2023 May; 68(5):299-311. PubMed ID: 35711159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.
    González-Ortega I; Echeburúa E; García-Alocén A; Vega P; González-Pinto A
    Trials; 2016 Jul; 17():372. PubMed ID: 27473688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.
    Makkos Z; Fejes L; Inczédy-Farkas G; Kassai-Farkas A; Faludi G; Lazary J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):212-7. PubMed ID: 21087649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.
    Madigan K; Brennan D; Lawlor E; Turner N; Kinsella A; O'Connor JJ; Russell V; Waddington JL; O'Callaghan E
    Schizophr Res; 2013 Jan; 143(1):138-42. PubMed ID: 23187069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of the predictors of health service utilisation by adults with mental disorders in the UK.
    Twomey CD; Baldwin DS; Hopfe M; Cieza A
    BMJ Open; 2015 Jul; 5(7):e007575. PubMed ID: 26150142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders.
    Baker AL; Hiles SA; Thornton LK; Hides L; Lubman DI
    Acta Psychiatr Scand; 2012 Oct; 126(4):243-55. PubMed ID: 22632145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
    Reid S; Bhattacharyya S
    Psychiatry Res; 2019 Oct; 280():112523. PubMed ID: 31450032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychiatric disorders in children and adolescents who have epilepsy.
    Jones JE; Austin JK; Caplan R; Dunn D; Plioplys S; Salpekar JA
    Pediatr Rev; 2008 Feb; 29(2):e9-14. PubMed ID: 18245299
    [No Abstract]   [Full Text] [Related]  

  • 36. [Psychiatric complications of cannabis use].
    Coscas S; Benyamina A; Reynaud M; Karila L
    Rev Prat; 2013 Dec; 63(10):1426-8. PubMed ID: 24579344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scoping Review of Cannabis-Reduction Psychosocial Interventions and Reasons for Use among Young Adults with Psychosis.
    Petros R; Walker DD; Pierce A; Monroe-DeVita M
    J Dual Diagn; 2023; 19(2-3):124-150. PubMed ID: 37391686
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies.
    Mammen G; Rueda S; Roerecke M; Bonato S; Lev-Ran S; Rehm J
    J Clin Psychiatry; 2018 Jun; 79(4):. PubMed ID: 29877641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Motivational interventions: psychosis and cannabis].
    Favrod J
    Encephale; 2009 Dec; 35 Suppl 6():S209-13. PubMed ID: 20141773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.